Abstract | BACKGROUND: METHODS: Twenty-three consecutive patients aged 21-79 were included to the study. In all patients 44 homogeneous, flat leukoplakia lesions were clinically diagnosed and confirmed histopathologically. Photodynamic therapy was performed with the use of Photolon(®) photosensitizer, containing 20% Chlorine-e6 and 10% dimethyl sulfoxide and a semiconductor laser, with power up to 300mW and a wavelength of 660nm. Ten illumination sessions were conducted with the use of superficial light energy density of 90J/cm(2). RESULTS: At baseline the mean size of leukoplakia lesion was 6.5±5.10cm(2) while after photodynamic therapy 3±2.99cm(2). Significant reduction (on average by 53.8%) of leukoplakia lesions sizes was observed after therapy. Twelve (27.27%) lesions had been completely cured, 22 (50%) partially cured, although 10 (22.73%) lasted unchanged. The efficacy of PTD was comparable in women and men irrespective of age. There have been no adverse site effects during therapy noted. CONCLUSIONS: Within the limits of the study it can be concluded that photodynamic therapy with the use of Chlorine-e6 can lead to considerable reduction of oral leukoplakia lesions size thus may be useful in clinical practice. However there is a need of further studies on larger number of cases and longer follow-up time.
|
Authors | Małgorzata Pietruska, Stefan Sobaniec, Piotr Bernaczyk, Magdalena Cholewa, Jan Krzysztof Pietruski, Ewa Dolińska, Anna Skurska, Ewa Duraj, Grażyna Tokajuk |
Journal | Photodiagnosis and photodynamic therapy
(Photodiagnosis Photodyn Ther)
Vol. 11
Issue 1
Pg. 34-40
(Mar 2014)
ISSN: 1873-1597 [Electronic] Netherlands |
PMID | 24211597
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Chlorophyllides
- Porphyrins
- Radiation-Sensitizing Agents
- phytochlorin
- Dimethyl Sulfoxide
|
Topics |
- Adult
- Chlorophyllides
- Dimethyl Sulfoxide
(therapeutic use)
- Female
- Humans
- Lasers, Semiconductor
- Leukoplakia, Oral
(radiotherapy)
- Low-Level Light Therapy
(methods)
- Male
- Middle Aged
- Porphyrins
(therapeutic use)
- Radiation-Sensitizing Agents
(therapeutic use)
|